Quick answer: there is no Wegovy patient assistance program in the sense of free medicine. The Novo Nordisk Patient Assistance Program’s 2026 product list covers Ozempic pens and several insulins, but not Wegovy.[1] The main ways to lower the cost of Wegovy are the $25 savings offer for commercial insurance, Novo’s self-pay prices starting at $149 a month, and Medicare’s $50 GLP-1 Bridge.[5][4][6]
Prices and program terms checked October 2026. They change often; confirm with the manufacturer or your plan.
Wegovy is the semaglutide brand approved for chronic weight management and to lower the risk of heart attack, stroke and cardiovascular death in adults with heart disease and overweight or obesity.[8] Because many plans do not cover weight-loss drugs, people often look for a free program.
Is Wegovy covered by the Novo Nordisk PAP?
No, based on the program’s current documents:
- The PAP’s current 2026 product list includes Ozempic pens, Xultophy, Fiasp, Novolin, NovoLog, NovoLog Mix 70/30, Tresiba, a NovoPen Echo device and NovoFine needles. Wegovy is not listed.[1]
- The PAP eligibility page sets income rules for Ozempic and insulins only, and says some medicines were removed from the program for 2026.[2]
- NovoCare’s Wegovy cost page lists the savings offer and self-pay prices but does not mention a patient assistance program.[3]
If you have heard otherwise, call the PAP line at 1-866-310-7549 to confirm. Programs change, and Novo can add or drop products at any time.[2]
Wegovy assistance options compared
| Option | Who it helps | Monthly cost |
|---|---|---|
| Wegovy savings offer | Commercial insurance that covers Wegovy | As little as $25 (max $100 off) |
| Self-pay pill | No coverage | $149 (1.5 mg), $199 (4 mg), $299 (9 or 25 mg) |
| Self-pay pen | No coverage | $199 intro (2 fills), then $349; HD 7.2 mg $399 |
| Medicare GLP-1 Bridge | Eligible Part D enrollees with obesity | $50 |
| Medicaid | Enrollees in states that cover obesity drugs | Small copay, varies by state |
| Clinical trial | People who meet a study’s criteria | Often $0 for study drug |
Sources: NovoCare,[4][5] Medicare.gov,[6] and KFF.[7]
Alternative 1: the Wegovy savings offer
If your commercial plan covers Wegovy, you can pay as little as $25 a month, with a maximum savings of $100 per 1-month fill. It works for both the pen and the pill. Medicare, Medicaid, VA, DOD and TRICARE enrollees are excluded.[5] See the Wegovy savings card.
Alternative 2: Novo Nordisk’s self-pay prices
Without coverage, Novo sells Wegovy at fixed cash prices through NovoCare Pharmacy and participating pharmacies:[4]
- Pill: $149 to $299 a month depending on dose.
- Pen: $349 a month for doses up to 2.4 mg, or $399 for Wegovy HD 7.2 mg.
- New patients: $199 for the first two pen fills of 0.25 mg or 0.5 mg, through December 31, 2026.
There is no income test. Full details are in Wegovy cost without insurance and Wegovy pill cost.
Alternative 3: Medicare’s GLP-1 Bridge
From July 1, 2026 through December 31, 2027, Medicare Part D enrollees can get Wegovy (pen or pill) for a $50 copay per month if they meet BMI criteria and get prior authorization.[6]
- BMI of 35 or higher; or
- BMI of 30 or higher with diastolic heart failure, uncontrolled high blood pressure or chronic kidney disease stage 3a or higher; or
- BMI of 27 or higher with prediabetes, a prior heart attack or stroke, or symptomatic peripheral artery disease.
People with type 2 diabetes, moderate-to-severe sleep apnea or fatty liver disease are not eligible for the Bridge, but their Part D plan may cover a GLP-1 for those conditions.[6]
Alternative 4: Medicaid
Federal law lets states choose whether Medicaid covers drugs for weight loss. KFF counted 13 states covering GLP-1s for obesity in fee-for-service Medicaid as of January 2026, down from 16 a year earlier. Where covered, prior authorization is typical.[7] Check your state Medicaid formulary or call the member services number on your card.
Alternative 5: clinical trials
Some studies of obesity medicines provide the study drug at no cost. You can search ClinicalTrials.gov for recruiting studies near you. Joining a trial means you may get a placebo, and you must follow the study’s visit schedule. More on this in how to get Ozempic for free.
A step-by-step plan if you need Wegovy and can’t afford it
- Confirm your diagnosis and goal with your clinician. If you have type 2 diabetes, a diabetes medicine may be covered where Wegovy is not.
- Check your insurance. Ask whether Wegovy is on your formulary, what prior authorization requires and what your copay would be. If it’s covered, enroll in the savings offer.[5]
- If you have Medicare, ask your prescriber about the GLP-1 Bridge and its BMI rules.[6]
- If you have Medicaid, check whether your state covers obesity drugs.[7]
- If none of these apply, compare the self-pay pill and pen prices and pick the form that fits your budget and routine.[4]
Recheck these options at least once a year. Employer plans change their drug lists at renewal, Medicaid rules change with state budgets, and the Medicare Bridge is a temporary program scheduled to end on December 31, 2027.[6]
Is free Ozempic from the PAP a substitute for Wegovy?
Not for most people. The PAP supplies Ozempic for its approved use in adults with type 2 diabetes, and only to uninsured people with household income at or below 200% of the federal poverty level.[2] If you have type 2 diabetes and qualify, your clinician may consider Ozempic for your diabetes, and weight loss may be one effect. But the program is not a route to semaglutide for weight management alone. Our guide on how to get Wegovy for free covers the realistic no-cost and low-cost routes, and does insurance cover Wegovy explains plan rules.
